HELP for AML: methylation profiling opens new avenues
- PMID: 20129241
- DOI: 10.1016/j.ccr.2009.12.033
HELP for AML: methylation profiling opens new avenues
Abstract
There is growing evidence that aberrant gene expression in cancer is linked to epigenetic deregulation like promoter cytosine methylation in CpG-islands. In this issue of Cancer Cell, Figueroa et al. show that genome-wide promoter DNA methylation profiling reveals unique AML subgroups and methylation patterns that are associated with clinical outcome.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Comment on
-
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.Cancer Cell. 2010 Jan 19;17(1):13-27. doi: 10.1016/j.ccr.2009.11.020. Epub 2010 Jan 7. Cancer Cell. 2010. PMID: 20060365 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical